NEWS: 公告在東京證券交易所JASDAQ標準市場新上市



Mass Spectrometry Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版商 Mordor Intelligence Pvt Ltd 商品編碼 391377
出版日期 內容資訊 英文 125 Pages
商品交期: 2-3個工作天內
質譜分析的全球市場:成長,趨勢及預測(2017年∼2022年) Mass Spectrometry Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
出版日期: 2021年05月13日內容資訊: 英文 125 Pages




第1章 簡介

  • 研究救濟策略
  • 市場定義
  • 數量單位
  • 基本貨幣
  • 檢討和預報期間的年齡
  • 調查的一般前提條件

第2章 調查方法

  • 簡介
  • 分析方法論
  • 計量經濟學的預測模式
  • 調查的前提條件

第3章 摘要整理

第4章 主要推論

第5章 市場概況及產業趨勢

  • 目前市場方案
  • 技術概要
  • 治療藥新的發展
  • 投資分析
  • 波特的五力分析
    • 供應商談判力
    • 買主談判力
    • 競爭程度
    • 替代品的威脅
    • 新加入廠商的威脅

第6章 成長要素,阻礙因素,機會及課題分析(DROC)

  • 市場成長要素
    • 在生命科學研究的政府支出的增加
    • 製藥產業的研究開發費的增加
    • 對食品的關注在食品、飲料產業中高漲
  • 市場阻礙因素
    • 設備的成本
    • 技術純熟勞工的缺乏
  • 市場機會
    • 水中的微量污染物質的監測
    • 蛋白質體學
    • 功能基因學
  • 主要課題

第7章 市場區隔

  • 各技術
    • 單一質譜分析
    • 混合質譜分析
  • 各產品
    • 設備
    • 試劑及消耗品
    • 服務
  • 各應用領域
    • 醫藥品
    • 生物科技
    • 工業化學
    • 環境實驗
    • 食品、飲料的實驗
    • 醫學研究

第10章 各地區市場:各地區佔有率及預測

  • 北美
    • 簡介
    • 美國
    • 加拿大
    • 其他
  • 歐洲
    • 簡介
    • 法國
    • 英國
    • 德國
    • 西班牙
    • 俄羅斯
    • 義大利
    • 其他
  • 亞太地區
    • 簡介
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 其他
  • 中東、非洲地區
    • 簡介
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 以色列
    • 其他MEA各國
  • 中南美
    • 簡介
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他

第11章 競爭情形

第12章 主要供應商

  • Agilent Technologies
  • Danaher Corporation
  • PerkinElmer Inc
  • Thermo Fisher Scientific
  • Bruker Corporation
  • Waters Corporation
  • 株式會社島津製作所
  • Leco Corporation.
  • Dani Instruments S.P.A.

第13章 分析師的投資機會預測

第14章 市場未來展望

第8章 附錄

  • 簡稱
  • 參考文獻
  • 免責聲明


Product Code: 49152

The mass spectrometry market registered a value of USD 4,975 million in 2020, and it is expected to reach USD 7,780 million by 2026, with a CAGR of nearly 7.4% during the forecast period, 2021-2026. Certain factors that are driving the market growth include the increasing technological advancements, growing concerns over food safety, and rising R&D expenditure by the pharmaceutical industry and government research organizations.

Mass spectrometry is one of the powerful tools used for the analysis of chemical and biological entities. In addition, the high demand from the biotechnology and pharmaceutical industries due to COVID-19 is driving the market. In 2020, in India, researchers at the Delhi-based Institute of Genomics and Integrative Biology (IGIB) and the National Centre for Disease Control (NCDC) were able to detect novel coronavirus (COVID-19) with 95% sensitivity and 100% specificity with respect to RT-PCR using a mass spectrometer.

According to the Organization for Economic Co-operation and Development (OECD), in 2018, in Germany, approximately 3.13% of GDP was spent on research and development, which was an increase from 3.07% of GDP in 2017 and 2.94% of GDP in 2016, respectively. Increasing investments in research and development activities are expected to increase the demand for mass spectrometer in drug development, proteomics, and pharmaceuticals, thereby driving the market growth.

Furthermore, advancements in mass spectroscopy technology were able to increase the factors like rapid test results with high resolution. The discovery of new tools has the potential to stimulate the usage of mass spectroscopy across drug development, pharmaceuticals, food safety testing, proteomics, and other fields.

The demands of life sciences applications have led to the improvement of mass spectrometry technologies. The mass spectrometry MALDI-ToF is used as a clinical diagnostic platform utilizing a highly advanced method of protein pattern recognition to diagnose diseases. Hence, with the increasing technological advancements, the market is expected to grow over the forecast period.

Key Market Trends

The Triple Quadrupole (Tandem) Segment is Expected to Hold a Significant Market Share

As per the scope of this report, mass spectrometry (MS) is an analytical chemistry technique used to identify the amount and type of chemical species present in a sample. Currently, the tandem mass spectrometry devices are among the most in-demand. Liquid chromatography-mass spectrometry (LC-MS/MS)-based approaches are considered reagent-free. The high sensitivity and specificity of mass spectrometry can overcome many limitations associated with immunoassays, such as cross-reactivity and non-specific antibody binding.

There is a higher demand for triple quadrupole mass spectrometer because triple quadrupole mass spectrometer is considered one of the most high-end instruments, and moreover, many labs across the world are adopting this instrument.

For instance, according to a research article by Malin Kallsten et al., published in the Analytical and Bioanalytical Chemistry Journal 2019, there has been a trend in mass spectrometry-based characterization of antibody-drug conjugates (ADCs) toward the use of high-resolving mass spectrometry for many of these analyses. Quadrupole mass spectrometers represent a viable alternative for the characterization of antibody-drug conjugates (ADCs) in early-stage drug development.

As per the Patented Medicine Prices Review Board 2018 report, in 2018, total R&D spending by the pharmaceutical industry was around CAD 0.89 billion, which was an increase from CAD 0.87 billion in 2017. Thus, the increasing R&D spending on pharmaceuticals is expected to drive the demand for mass spectrometers in the near future.

Moreover, a UK biotech laboratory has used mass spectrometry for coronavirus testing. In April 2020, the UK diagnostics firm MAP Sciences announced the development of a rapid test for the COVID-19 virus. This technology deploys mass spectrometry to spot proteins that are unique to COVID-19 and is targeting to deliver test results within 30 minutes. These advancements are expected to fuel the growth of the studied market.

North America is Expected to Hold a Major Market Share Over the Forecast Period

The major factors driving the market growth in the North American region include the growing funding for research and government initiatives in the United States, widespread usage of mass spectrometry in the metabolomics and petroleum sectors, and the presence of key market players.

The US government spends a significant percentage of its GDP on R&D. According to a 2018 report published by the Organization for Economic Co-operation and Development (OECD), about 2.82% of the country's GDP was spent on R&D. In addition, in 2019, the research and development (R&D) expenditure of the US pharmaceutical industry was around USD 83 billion up from USD 79.6 billion in 2018 and USD 71.4 billion in 2017. Thus, increasing R&D activities increase the demand for mass spectrometers and drive the market growth.

Drug development is an expensive and lengthy process, and the failure rate is also high. Factors such as long time periods, high failure rates, and high costs are forcing researchers to look for newer technologies.

Additionally, mass spectroscopy is also being used in clinical laboratories to measure small sample volumes with improved confidence across an expanding range of healthcare applications, from toxicology to personalized medicine.

As per a September 2020 article published in Oxford Academics, in the United States, response to the COVID-19 pandemic has been hampered by inadequate testing resources. Therefore, technologies such as matrix-assisted laser desorption/ionization combined with mass spectrometry (MALDI-MS) are used to provide faster and cheaper diagnoses, which may drive their demand over the forecast period.

Competitive Landscape

The mass spectrometry market is highly competitive. The leading players offer an expansive product portfolio for mass spectrometers and have a broad geographic presence. Companies like Agilent Technologies, Bruker Corporation, Danaher Corporation, Leco Corporation, Perkin Elmer Inc., Shimadzu Corporation, Thermo Fisher Scientific, and Waters Corporation, among others, hold a substantial share in the mass spectrometry market.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support



  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study




  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Technological Advancements
    • 4.2.2 Growing Concerns Over Food Safety
    • 4.2.3 Rising R&D Expenditure by Pharmaceutical Industry and Government Research Organizations
  • 4.3 Market Restraints
    • 4.3.1 High Costs of Instruments
    • 4.3.2 Lack of Skilled Technicians
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry


  • 5.1 By Technology
    • 5.1.1 Hybrid Mass Spectrometry
      • Triple Quadrupole (Tandem)
      • Quadrupole TOF (Q-TOF)
      • FTMS (Fourier Transform Mass Spectrometry)
    • 5.1.2 Single Mass Spectrometry
      • ION Trap
      • Quadrupole
      • Time-of-Flight (TOF)
    • 5.1.3 Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
  • 5.2 By Application
    • 5.2.1 Pharmaceuticals Industry
    • 5.2.2 Biotechnology Industry
    • 5.2.3 Chemical Industry
    • 5.2.4 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • United States
      • Canada
      • Mexico
    • 5.3.2 Europe
      • Germany
      • United Kingdom
      • France
      • Italy
      • Spain
      • Rest of Europe
    • 5.3.3 Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • GCC
      • South Africa
      • Rest of Middle-East and Africa
    • 5.3.5 South America
      • Brazil
      • Argentina
      • Rest of South America


  • 6.1 Company Profiles
    • 6.1.1 Agilent Technologies
    • 6.1.2 Bruker Corporation
    • 6.1.3 Danaher Corporation
    • 6.1.4 Hitachi Ltd
    • 6.1.5 JEOL Ltd
    • 6.1.6 LECO Corporation
    • 6.1.7 MKS Instruments
    • 6.1.8 PerkinElmer Inc.
    • 6.1.9 Shimadzu Corporation
    • 6.1.10 Thermo Fisher Scientific
    • 6.1.11 Waters Corporation